Business Context and Reporting Period
Company: Flora Growth Corp. (Note: Request metadata referenced "Zerostack Corp.", but the filing identifies the registrant as Flora Growth Corp.)
Filing Type: Form 8-K (Current Report)
Date: September 23, 2025
Event: Entry into a Material Definitive Agreement (At-the-Market Sales Agreement).
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It details the terms of a potential equity offering.
| Item | Details |
|---|---|
| Agreement Type | At-the-Market (ATM) Sales Agreement |
| Agent | Revere Securities LLC |
| Securities | Common Shares, no par value (Symbol: FLGC) |
| Commission Structure | 3.00% on first $150M; 2.00% on next $350M; 1.25% on proceeds over $500M |
| Use of Proceeds | General corporate purposes |
Material Changes
There are no material changes to financial performance reported in this filing. The material change is the establishment of a mechanism to sell common shares in the open market, subject to market conditions and company discretion.
Guidance, Outlook, and Risks
- Management Commentary: The Company is not obligated to make any sales under the agreement. Sales may be suspended by the Company or Agent upon proper notice.
- Outlook: The Company intends to use net proceeds for general corporate purposes.
- Risks/Contingencies: The Company has agreed to indemnify the Agent against certain liabilities under the Securities Act. The offering is subject to the rules of the Nasdaq Capital Market and applicable laws.
- Unusual Items: None reported.
Investor Verification Checklist
- Verify the current share count and potential dilution impact if the Company exercises the ATM facility.
- Review the attached Sales Agreement (Exhibit 1.1) for specific termination rights and price designation mechanisms.
- Confirm the Company's current cash position to assess the immediate necessity of raising capital via this ATM.
- Monitor future filings for actual sales activity and proceeds generated under this agreement.